# ZARXIO

NDC: 61314-326
Generic name: filgrastim-sndz
Labeler / Manufacturer: Sandoz Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20150306

FDA application: BLA125553

## Active ingredients

- FILGRASTIM: 480 ug/.8mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61314-326"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61314-326
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c0d1c22b-566b-4776-bdbf-00f96dad0cae